drugset / Trial / NCT00017368

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma

NCT00017368 ↗

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy followed by peripheral stem cell transplantation in treating children who have newly diagnosed neuroblastoma.

Timeline

Start
2001-04
Primary completion
2005-09
Completion
2012-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule — Intravenous
Subject Cisplatin Other / unclassified — Intravenous
Subject Cyclophosphamide Other / unclassified — Intravenous
Subject Doxorubicin Other / unclassified — Intravenous
Subject Etoposide Small molecule — Intravenous
Subject Ifosfamide Small molecule — Intravenous
Subject Isotretinoin Other / unclassified — Oral
Subject Melphalan Small molecule — Intravenous
Subject Thiotepa Other / unclassified — Intravenous
Subject Vincristine Small molecule — Intravenous
Subject filgrastim Protein / enzyme biologic — Subcutaneous
Subject sargramostim Protein / enzyme biologic — Subcutaneous

Indications